Annals of Clinical Microbiology, The official Journal of the Korean Society of Clinical Microbiology

6

Weeks in Review

2

Weeks to Publication
Indexed in KCI, KoreaMed, Synapse, DOAJ
Open Access, Peer Reviewed
pISSN 2288-0585 eISSN 2288-6850
Corrigenda

Corrigenda 2024.08.05.

Ann Clin Microbiol 2024;27(3). https://doi.org/10.5145/ACM.2024.27.2.10
Published on 5 August 2024.
Copyright © Korean Society of Clinical Microbiology.

To enhance understanding and ensure the transparency of research, we have made important updates to following articles previously published in our journal. We apologize for any inconvenience these modifications may cause. Our commitment to maintaining the highest standards of research integrity and publication transparency remains steadfast. We appreciate the understanding and continued support of our readers and contributors.

YearVol.IssuePagesTitleUpdate
20222511-10Multidrug-resistant gram-negative bacterial infections the Tamale Teaching Hospital in Northern Ghana: a three-year retrospective analysisThe “Ethics statement” and “Conflicts of interest” have been added.
202225231-39Inhibitory effects of copper, brass, and stainless steel surfaces on multidrug-resistant microorganismsThe “Ethics statement” has been added.
202225253-59Current prevalence of the crpP gene in carbapenemase-producing Pseudomonas aeruginosa blood isolates in KoreaThe “Ethics statement” and “Conflicts of interest” have been added.
202225261-65Book review: “The New Microbiology: From Microbiomes to CRISPR”The “Ethics statement” has been added.
202225367-72EUCAST v.12.0 review focused on changesThe “Ethics statement” has been added.
202225397-102The first case of bacteremia caused by Bordetella hinzii in KoreaThe “Ethics statement” has been added.
2022254109-118Clinical usefulness of the QMAC-dRAST system for AmpC β-lactamase-producing EnterobacteralesThe “Conflicts of interest” has been added.
2022254125-136Assessment of the synergistic effect of seven antimicrobial combinations on extensively drug-resistant Acinetobacter baumannii strainsThe “Ethics statement” has been added.
2022254137-145Antimicrobial resistance patterns of Acinetobacter baumannii and Pseudomonas aeruginosa isolated from vulnerable patients in Korea, 2021The “Conflicts of interest” has been added.
2022254155-160A case report of Gemella sanguinis isolated from blood cultures of a patient with mitral valve prolapseThe “Ethics statement” has been added.
20232611-9Syndromic testing for sexually transmitted infection: current and future demandThe “Ethics statement” has been added.
202326111-17Epidemiology and subtype distribution of Blastocystis among asymptomatic volunteers in Korea: a multicenter studyThe “Conflicts of interest” has been added.
202326229-36Risk factors associated with colistin-resistant Acinetobacter baumannii infectionThe “Conflicts of interest” has been added.
202326341-50Group B Streptococcus vaccines: progress and potentialThe “Ethics statement” has been added.
202326351-57Introduction to the revised international guidelines on breakpoints for antimicrobial susceptibility testingThe “Ethics statement” has been added.
202326367-73Multicenter study on the molecular epidemiology of intestinal protozoan parasites in KoreaThe “Conflicts of interest” has been added.
202326375-82A survey of physicians’ perceptions of diagnostic tests for Clostridioides difficile infectionThe “Ethics statement” and “Conflicts of interest” have been added.
202326383-86SARS-CoV2 mutation detection experience using PowerChek SARS-CoV-2 S-gene Mutation Detection KitThe “Ethics statement” has been added.
2023263125-137Performance evaluation of 4-day versus 5-day blood cultures using the BD BACTEC FX systemThe “Ethics statement” has been added.
2023264139-145Comparative evaluation of critical concentrations for detecting borderline rifampin resistance in Mycobacterium tuberculosisThe “Ethics statement” has been added.
2023264147-157Analysis of blood culture data at a university hospital: bacterial distribution and cumulative antimicrobial resistance (2016–2020)The “Ethics statement” has been added.
202427119-30Prevalence of Helicobacter pylori infection and clarithromycin resistance rate from 2015 to 2018 in Korea: a repeated cross-sectional studyThe title has been changed from “Prevalence of Helicobacter pylori infection and clarithromycin resistance rate from 2015 to 2018 using the laboratory information system of the Seegene Medical Foundation in Korea: a repeated cross-sectional study”.
Table